Main Article Content
Abstract
Keywords
Article Details
-
Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:
Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
You are free to :
Share ” copy and redistribute the material in any medium or format.
Adapt ” remix, transform, and build upon the material.
References
- Amri A, Chaunnel JC, Charruan C (2012). Administration of resveratrol: what formulation solutions to bioavaibility limitations. Journal of controlled release, 182-193
- Chatterjee P, Bagchi S, Sengupta (2014). The uniform early structural response of globural proteins to cold denaturing conditions:a case study. J Chem Phys.,141
- Chen X, He H, Wang G, Yang B, Ren W, Ma L, Yu (2007). Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC: application to pharmacokinetic studies. Biomedical Chromatography 21, 257-265
- Chinsriwongkul A, Ponwanit C, Tanasait N, Theerasak R, Warisada Sila-on., Ruktanonchai, Praneet O (2011). Nanostructured Lipid Carriers (NLC) for parenteral delivery of an anticancer drug. American Association of Pharmaceutical Sciences 13, 150-158
- Farris PK (2014). Cosmeceuticals and cosmetic practice. USA, John Wiley & Sons Ltd, p 165-172
- Gerszon J, Aleksandra R, Mieczyslaw P (2014). Antioxidant properties of resveratrol and its protective effects in neurodegenerative diseases, 97-117
- Gokce, Emrah K, Eleonora D, Giuseppina S, Bonferoni MC, OzgenO (2012). Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. International Journal of Nanomedicine 7, 1841-1850
- Hu F, Qiang, Sai-P J, Yong-Z D, Hong Y, Yi-Qing Y, Su Z (2005). Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system colloids and surfaces B. Biointerfaces 45, 167-173
- Junyapraset V, Supaporn P (2008). Floating properties and release characteristic of hollow microspheres of acyclovir. Drug Delivery 15, 331-341
- Kim S, Wai KN, Yuangcai D, Surajit D, Reginald T (2012). Preparation and physochemical characterization of trans-resveratrol nanoparticle by temperature-controlled antisolvent precipitation. Journal of Food Enggineering 108, 37-42
- Li B, Ge ZQ (2012). Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone. American Association of Pharmaceutical Sciences, 276-283
- Liang L, Tajmir-Riahi HA, Muriel S (2008). Interaction of b lactoglobulin with resveratrol and its biological implications. Biomacromolecules 9, 50-56
- Loo CH, Basri M, Ismail R, Lau HLN, Tejo BA, Kanthimathi MS, Hassan HA, Choo YM (2013). Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion. International Journal of Nanomedicine 8, 13-22
- Neves AR, Marlene L, Susana M, José LC, Salette R (2013). Resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. International Journal of Nanomedicine 8, 177-187
- Pardeike J, Aiman H, Rainer H, Muller (2009). Lipid nanoparticle (LN, NLC) in Cosmetic and Pharmacheutical. International Journal Of Pharmacceutics 366, 170-184
- Pezeshki A, Ghanbarzadeh B, Mohammadi M, Isa F, Hamed H (2014). Encapsulation of vitamin A palmitate in Nanostructured Lipid Carrier (NLC)-effect of surfactant concentration on the formulation propertie. Advances Pharmaceutical Bulletin 4, 563-568
- Putranti AR, Riesta P, Esti H (2017). Effectivity and physicochemical stability of nanostructured lipid carrier coenzyme q10 in different ratio of lipid cetyl palmitate and alpha tocopheryl acetate as carrier. Asian J Pharm Clin Res 10, 147-151
- Raymundo A, Franco JM, Empi J, Sousa I (2001). Optimazation of the composition low fat oil in water emulsion stabilized by with protein. Journal American oil Chemist 79, 783-790
- Rosa NAB (2011). Development of nanoparticles loaded with bioactive compounds for application as nutraceuticals. A dissertation. Engineering of Oporto University, p 60-69
- Sinko P (2011). Physical pharmacy and pharmaceutical science. 6th Ed. China, Lippincont William and Wilkins, p 355-367, 469-473
- Spitzer JJ (2003). Colloidal interactions: contact limiting laws, double-layer dissociation and non-DLVO. Colloidal and Polymer Scieence, 589-592
- Sun RG, Zhao S, Ni Q, Xia (2014). Lipid based nanocarriers with different lipid compositions for topical delivery of resveratrol: Comparative analysis of characteristics and performance. Journal of Drug Delivery Science and Technology 24, 591-600
- Wu L, Zhang J, Watanabe (2011). Physical and chemichal stability of drug nanoparticle. Adv Drug Delivery, 456-69
- Zupancic, Å pela ZL, Julijana K (2014). Stability and solubility of trans-resveratrol are strongly influence by pH and temperature. European Journal of Pharmaceutics and Biopharmaceutics, p 1-29
References
Amri A, Chaunnel JC, Charruan C (2012). Administration of resveratrol: what formulation solutions to bioavaibility limitations. Journal of controlled release, 182-193
Chatterjee P, Bagchi S, Sengupta (2014). The uniform early structural response of globural proteins to cold denaturing conditions:a case study. J Chem Phys.,141
Chen X, He H, Wang G, Yang B, Ren W, Ma L, Yu (2007). Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC: application to pharmacokinetic studies. Biomedical Chromatography 21, 257-265
Chinsriwongkul A, Ponwanit C, Tanasait N, Theerasak R, Warisada Sila-on., Ruktanonchai, Praneet O (2011). Nanostructured Lipid Carriers (NLC) for parenteral delivery of an anticancer drug. American Association of Pharmaceutical Sciences 13, 150-158
Farris PK (2014). Cosmeceuticals and cosmetic practice. USA, John Wiley & Sons Ltd, p 165-172
Gerszon J, Aleksandra R, Mieczyslaw P (2014). Antioxidant properties of resveratrol and its protective effects in neurodegenerative diseases, 97-117
Gokce, Emrah K, Eleonora D, Giuseppina S, Bonferoni MC, OzgenO (2012). Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. International Journal of Nanomedicine 7, 1841-1850
Hu F, Qiang, Sai-P J, Yong-Z D, Hong Y, Yi-Qing Y, Su Z (2005). Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system colloids and surfaces B. Biointerfaces 45, 167-173
Junyapraset V, Supaporn P (2008). Floating properties and release characteristic of hollow microspheres of acyclovir. Drug Delivery 15, 331-341
Kim S, Wai KN, Yuangcai D, Surajit D, Reginald T (2012). Preparation and physochemical characterization of trans-resveratrol nanoparticle by temperature-controlled antisolvent precipitation. Journal of Food Enggineering 108, 37-42
Li B, Ge ZQ (2012). Nanostructured lipid carriers improve skin permeation and chemical stability of idebenone. American Association of Pharmaceutical Sciences, 276-283
Liang L, Tajmir-Riahi HA, Muriel S (2008). Interaction of b lactoglobulin with resveratrol and its biological implications. Biomacromolecules 9, 50-56
Loo CH, Basri M, Ismail R, Lau HLN, Tejo BA, Kanthimathi MS, Hassan HA, Choo YM (2013). Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion. International Journal of Nanomedicine 8, 13-22
Neves AR, Marlene L, Susana M, José LC, Salette R (2013). Resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. International Journal of Nanomedicine 8, 177-187
Pardeike J, Aiman H, Rainer H, Muller (2009). Lipid nanoparticle (LN, NLC) in Cosmetic and Pharmacheutical. International Journal Of Pharmacceutics 366, 170-184
Pezeshki A, Ghanbarzadeh B, Mohammadi M, Isa F, Hamed H (2014). Encapsulation of vitamin A palmitate in Nanostructured Lipid Carrier (NLC)-effect of surfactant concentration on the formulation propertie. Advances Pharmaceutical Bulletin 4, 563-568
Putranti AR, Riesta P, Esti H (2017). Effectivity and physicochemical stability of nanostructured lipid carrier coenzyme q10 in different ratio of lipid cetyl palmitate and alpha tocopheryl acetate as carrier. Asian J Pharm Clin Res 10, 147-151
Raymundo A, Franco JM, Empi J, Sousa I (2001). Optimazation of the composition low fat oil in water emulsion stabilized by with protein. Journal American oil Chemist 79, 783-790
Rosa NAB (2011). Development of nanoparticles loaded with bioactive compounds for application as nutraceuticals. A dissertation. Engineering of Oporto University, p 60-69
Sinko P (2011). Physical pharmacy and pharmaceutical science. 6th Ed. China, Lippincont William and Wilkins, p 355-367, 469-473
Spitzer JJ (2003). Colloidal interactions: contact limiting laws, double-layer dissociation and non-DLVO. Colloidal and Polymer Scieence, 589-592
Sun RG, Zhao S, Ni Q, Xia (2014). Lipid based nanocarriers with different lipid compositions for topical delivery of resveratrol: Comparative analysis of characteristics and performance. Journal of Drug Delivery Science and Technology 24, 591-600
Wu L, Zhang J, Watanabe (2011). Physical and chemichal stability of drug nanoparticle. Adv Drug Delivery, 456-69
Zupancic, Å pela ZL, Julijana K (2014). Stability and solubility of trans-resveratrol are strongly influence by pH and temperature. European Journal of Pharmaceutics and Biopharmaceutics, p 1-29